Katarina Vučićević

21PUBLICATIONS
29CO-AUTHORS
Medical biochemistry - inorganic elements and compoundsAutoimmunityRheumatology and arthritisPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Sep 26, 2026
Connecting the Dots Between Pharmacokinetics, Inflammatory Biomarkers, and Mucosal Healing in Patients on Infliximab with Inflammatory Bowel Disease.

|Aug 27, 2026
Adalimumab Safety in Inflammatory Bowel Disease: A Clinical Cohort Study with Time-to-Event Analysis and FAERS Signal Assessment.

|Jul 28, 2026
Unlocking the Potential of Population Pharmacokinetic Models of Adalimumab in Patients with Crohn's Disease.

|Jul 24, 2026
Pharmacokinetic model selection for infliximab based on inflammatory bowel disease phenotype and severity: Toward model-informed precision dosing.

|Jun 26, 2026
Prioritizing Antidiabetic Drugs for Inflammatory Bowel Disease Through Inverse Signal Detection: A FAERS Pharmacovigilance Study.

|May 27, 2026
Population Pharmacokinetic Models at the Forefront of Precision Dosing.

Pageof 4

Frequent Collaborators

7 joint publications

Branislava Miljković

6 joint publications

Petar Svorcan

5 joint publications

Marija Jovanović

4 joint publications

Srđan Marković